NL-OMON24258CompletedNot Applicable
RCT: Population screening for colorectal cancer by colonoscopy or CT-colonography in the Netherlands.
Primary initiators: Academic Medical Center (AMC) and Erasmus Medical Center, Department of Gastroenterology & Hepatology and department of Radiology.0 sites7,500 target enrollmentStarted: TBDLast updated:
Conditions
Trial Snapshot
- Phase
- Not Applicable
- Status
- Completed
- Sponsor
- Enrollment
- 7,500
Study Overview
Brief Summary
/A
Study Design
- Study Type
- Interventional
Eligibility Criteria
Inclusion Criteria
- •1. Asymptomatic individuals between 50 and 74 years of age;
- •2. Individuals living in pre-selected postal areas in Amsterdam and Rijnmond region.
Exclusion Criteria
- •1. Participants in previous CRC population screening trials;
- •2. Complete colonoscopy performed within the last 5 years;
Investigators
Similar Trials
Active, not recruiting
Phase 1
Investigation of the effects of cues to action on participation in colorectal (CRC) screening - the role of implementation intentionsACTRN12607000147482Commonwealth Scientific and Industrial Research Organisation (CSIRO) Preventative Health Flagship3,200
Not yet recruiting
Not Applicable
Implementation of population screening for colorectal cancer by repeated fecal occult blood test in the Netherlandscolorectal cancer, average risk individualsNL-OMON23143Dep. of Gastroenterology, Academic Medical Center Amsterdam10,000
Not yet recruiting
Not Applicable
Implementation of population screening for colorectal cancer by repeated Fecal Immunochemical Test (FIT): 3 round.NL-OMON26636Initiator: Academic Medical Centre (AMC), departement of Gastroenterology & Hepatology. Co-centre: Flevoziekenhuis Almere10,000
Completed
Not Applicable
Colon cancer detection by measuring DNA of cells collected from rectum: A pilot studyinflammatory bowel diseaseColorectalCancerColorectal cancerISRCTN30255103Colonix Medical Ltd (UK)190
Completed
Not Applicable
Colon cancer detection by measuring DNA of cells collected from rectum: A case-control studyMalignant neoplasm of colonColorectal cancerCancerISRCTN95403112Colonix Medical Ltd (UK)170